Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...
As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
13h
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...
New anti-obesity drugs should meet a minimum level of weight loss to be considered for approval, the FDA said ...
Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.
Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...
On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback